Loading news...
8 Knots Management LLC boosted its stake in shares of Enhabit, Inc. (NYSE: EHAB) by 9.5% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,218,846 shares of the company's stock after purchasing an additional 365,779 shares during the quarter. Enhabit comprises 3.8%
Dynamic Technology Lab Private Ltd reduced its holdings in shares of Enhabit, Inc. (NYSE: EHAB) by 57.6% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 31,541 shares of the company's stock after selling 42,823 shares during the period.
With the CBOE Volatility Index (VIX) sitting at 25.50 and up 34.9% over the past month, investors are increasingly rotating toward names that offer stability, predictable income, and low correlation to broader market swings.
Enhabit (NYSE: EHAB - Get Free Report) and Agilon Health (NYSE: AGL - Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, dividends, valuation, analyst recommendations, risk and earnings. Analyst Ratings This is a breakdown of current
NEW YORK, March 05, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde and Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report.
PHILADELPHIA, March 05, 2026 (GLOBE NEWSWIRE) -- Kaskela Law LLC has launched an investigation into the fairness of the recently announced proposed buyout of Enhabit, Inc. (NYSE: EHAB) shareholders to determine whether the $13.80 per share buyout price undervalues the company's shares. Click here to request additional information: https://kaskelalaw.com/case/enhabit/ On February 23, 2026, Enhabit announced that it had agreed to be acquired by private equity firm Kinderhook Industries at a price of $13.80 per share in cash.
Enhabit (EHAB) came out with quarterly earnings of $0.14 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.04 per share a year ago.
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the fourth quarter ended Dec. 31, 2025. “Our fourth quarter 2025 results capped a pivotal year for Enhabit, delivering an emerging growth story with year over year increases in patient census, revenue and Adjusted EBITDA,” said Barb Jacobsmeyer, CEO and president of Enhabit. “The consistent execution of our strategy throughout the year materially imp.
Enhabit, Inc. (NYSE: EHAB - Get Free Report) has earned a consensus rating of "Hold" from the nine research firms that are currently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, five have given a hold rating and three have given a buy rating to the company.
Enhabit (EHAB) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Enhabit (NYSE: EHAB - Get Free Report) is anticipated to release its Q4 2025 results after the market closes on Wednesday, March 4th. Analysts expect Enhabit to post earnings of $0.14 per share and revenue of $270.5590 million for the quarter. Parties may visit the the company's upcoming Q4 2025 earning results page for the latest
NEW YORK, Feb. 24, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Enhabit Inc. (NYSE: EHAB) related to its sale to Kinderhook Industries, LLC.
Bala Cynwyd, Pennsylvania--(Newsfile Corp. - February 24, 2026) - Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Enhabit, Inc. ("Enhabit" or the "Company") (NYSE: EHAB) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to Kinderhook Industries, LLC ("Kinderhook") for $13.80 a share in an all-cash transaction for a total enterprise value of approximately $1.1 billion. The investigation concerns whether the Enhabit Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration provides fair value to the Company's shareholders.
Enhabit (EHAB) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Enhabit, Inc. (NYSE: EHAB) to Kinderhook Industries, LLC. Under the terms of the proposed transaction, shareholders of Enhabit will receive $13.80 per share in cash. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration under.
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Enhabit, Inc. (NYSE: EHAB) to Kinderhook Industries, LLC for $13.80 per share in cash. Halper Sadeh encourages Enhabit shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns whether Enhabit and its board of directors violate.
MILWAUKEE, Feb. 23, 2026 /PRNewswire/ -- Ademi LLP is investigating Enhabit (NYSE: EHAB) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Kinderhook Industries. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995.
DALLAS & NEW YORK--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it has entered into a definitive agreement to be acquired by Kinderhook Industries, LLC (“Kinderhook”), a middle market private equity firm, in an all-cash transaction for a total enterprise value of approximately $1.1 billion. Under the terms of the agreement, Enhabit stockholders will receive $13.80 per share in cash, which represents a premium of approximately.
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it will report its financial results for the fourth quarter and fiscal year ended Dec. 31, 2025, on March 4, 2026, and host a webcast and conference call on March 5, 2026. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time. March 5, 2026 9 a.m. EST Toll-free: 888-660-6150 International: 929-203-0843.